Gene · 1810
Papers3,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure. | Front Microbiol | 2022 | 36118192 | PubTator, text mining | PubMed |
| The role of pregnane X receptor (PXR) in substance metabolism. | Front Endocrinol (Lausanne) | 2022 | 36111293 | PubTator, text mining | PubMed |
| The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis. | Front Pharmacol | 2022 | 36110516 | PubTator, text mining | PubMed |
| Experiences of Native Participants in the Promoting First Relationships® Intervention: Focus Group Findings. | Matern Child Health J | 2022 | 36109420 | PubTator, text mining | PubMed |
| Functional cure of hepatitis B requires silencing covalently closed circular and integrated hepatitis B virus DNA. | J Clin Invest | 2022 | 36106633 | PubTator, text mining | PubMed |
| Host and bacterial factors linking periodontitis and rheumatoid arthritis. | Front Immunol | 2022 | 36091038 | PubTator, text mining | PubMed |
| Delta-like ligand-4 regulates Notch-mediated maturation of second heart field progenitor-derived pharyngeal arterial endothelial cells. | J Cell Mol Med | 2022 | 36082581 | PubTator, text mining | PubMed |
| Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD. | Cells | 2022 | 36078093 | PubTator, text mining | PubMed |
| Deciphering the Regulatory Circuits of RA3 Replication Module - Mechanisms of the Copy Number Control. | Int J Mol Sci | 2022 | 36077372 | PubTator, text mining | PubMed |
| The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells. | Int J Mol Sci | 2022 | 36077103 | PubTator, text mining | PubMed |
| In vivo and in vitro per se effect evaluation of Polycaprolactone and Eudragit® RS100-based nanoparticles. | Biomed Pharmacother | 2022 | 36076536 | PubTator, text mining | PubMed |
| Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression? | Front Pharmacol | 2022 | 36059987 | PubTator, text mining | PubMed |
| Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches. | Front Immunol | 2022 | 36059456 | PubTator, text mining | PubMed |
| Nanoscale Kevlar Liquid Crystal Aerogel Fibers. | ACS Nano | 2022 | 36053080 | PubTator, text mining | PubMed |
| Improved disease diagnosis system for COVID-19 with data refactoring and handling methods. | Front Psychol | 2022 | 36033018 | PubTator, text mining | PubMed |
| Humanized CD19-directed CAR-T Cell Therapy in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia With CNSL or Neurological Comorbidity. | J Immunother | 2022 | 36018262 | PubTator, text mining | PubMed |
| Associations between heart rate asymmetry expression and asymmetric detrended fluctuation analysis results. | Med Biol Eng Comput | 2022 | 36001222 | PubTator, text mining | PubMed |
| Pancreas agenesis mutations disrupt a lead enhancer controlling a developmental enhancer cluster. | Dev Cell | 2022 | 35998583 | PubTator, text mining | PubMed |
| Association of specific HLA alleles and haplotypes with pemphigus vulgaris in the Bulgarian population. | Front Immunol | 2022 | 35983062 | PubTator, text mining | PubMed |
| Genetic basis of defects in immune tolerance underlying the development of autoimmunity. | Front Immunol | 2022 | 35979360 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1810/papers?page=16